Kaliumklorid Noridem

Potassium Chloride, the active ingredient in Kaliumklorid Noridem, is a potassium supplement presented as an injectable solution for IV use. It restores extracellular potassium levels and corrects hypokalemia in patients with potassium depletion. It is indicated for adult patients who require rapid potassium repletion under medical supervision.

GNH USA supplies Kaliumklorid Noridem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance.

Kaliumklorid Noridem (potassium chloride) is used to treat conditions involving potassium loss or deficiency.

- Hypokalemia: restores normal serum potassium levels to reduce muscle weakness and cardiac risk. - Potassium depletion: replenishes extracellular potassium during prolonged diuresis or gastrointestinal loss. - Prevention of arrhythmias in at‑risk patients: maintains adequate potassium to support cardiac electrical stability.

Adverse reactions may occur with intravenous potassium chloride administration.

Common Side Effects: - Infusion site pain or irritation. - Nausea or vomiting. - Transient hypotension. - Headache. - Mild hyperkalemia (elevated serum potassium). - Local phlebitis.

Serious or Rare Side Effects: - Severe hyperkalemia leading to cardiac arrhythmia. - Cardiac arrest. - Anaphylactic or severe allergic reaction. - Tissue necrosis if extravasation occurs. - Life‑threatening ventricular tachycardia.

Use of Kaliumklorid Noridem requires careful clinical monitoring. - Renal impairment: adjust dose and monitor serum potassium closely. - Cardiac disease: continuous ECG monitoring is recommended. - Concomitant ACE inhibitors or ARBs: increased risk of hyperkalemia; monitor levels. - Pregnancy: administer only if clearly needed after risk‑benefit assessment. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Potassium chloride can interact with several medications that affect potassium balance.

Major Interactions (Avoid): - ACE inhibitors: may cause dangerous hyperkalemia. - Potassium‑sparing diuretics (e.g., spironolactone): risk of severe hyperkalemia. - ARBs: additive effect on serum potassium levels.

Moderate Interactions (Monitor Closely): - NSAIDs: can reduce renal potassium excretion, raising serum levels. - Digoxin: altered potassium may affect digoxin toxicity risk.